Abstract:<h3 class="Heading">Background</h3><p class="Para">High-grade endometrioid and serous endometrial cancers (ECs) are an aggressive subtype of ECs without effective therapies. The reciprocal communication between tumor cells and their surrounding microenvironment drives tumor progression. Long noncoding RNAs (lncRNAs) are key mediators of tumorigenesis and metastasis. However, little is known about the role of lncRNAs in aggressive EC progression and tumor microenvironment remodeling.</p><h3 class="Heading">Methods</h3><p class="Para">We performed an array-based lncRNA analysis of a parental HEC-50 EC cell population and derivatives with highly invasive, sphere-forming, and paclitaxel (TX)-resistant characteristics. We characterized the roles of the lncRNA NEAT1 in mediating aggressive EC progression in vitro and in vivo and explored the molecular events downstream of NEAT1.</p><h3 class="Heading">Results</h3><p class="Para">We identified 10 lncRNAs with upregulated expression (NEAT1, H19, PVT1, UCA1, MIR7-3HG, SNHG16, HULC, RMST, BCAR4 and LINC00152) and 10 lncRNAs with downregulated expression (MEG3, GAS5, DIO3OS, MIR155HG, LINC00261, FENDRR, MIAT, TMEM161B-AS1, HAND2-AS1 and NBR2) in the highly invasive, sphere-forming and TX-resistant derivatives. NEAT1 expression was markedly upregulated in early-stage EC tissue samples, and high NEAT1 expression predicted a poor prognosis. Inhibiting NEAT1 expression with small hairpin RNAs (shRNAs) diminished cellular proliferation, invasion, sphere formation, and xenograft tumor growth and improved TX response in aggressive EC cells. We showed that NEAT1 functions as an oncogenic sponge for the tumor suppressor microRNA-361 (miR-361), which suppresses proliferation, invasion, sphere formation and TX resistance by directly targeting the oncogene STAT3. Furthermore, miR-361 also suppressed the expression of multiple prometastatic genes and tumor microenvironment-related genes, including <em class="EmphasisTypeItalic">MEF2D</em>, <em class="EmphasisTypeItalic">ROCK1</em>, <em class="EmphasisTypeItalic">WNT7A</em>, <em class="EmphasisTypeItalic">VEGF-A</em>, <em class="EmphasisTypeItalic">PDE4B,</em> and <em class="EmphasisTypeItalic">KPNA4</em>.</p><h3 class="Heading">Conclusions</h3><p class="Para">NEAT1 initiates a miR-361-mediated network to drive aggressive EC progression. These data support a rationale for inhibiting NEAT1 signaling as a potential therapeutic strategy for overcoming aggressive EC progression and chemoresistance.</p>

Molecular Mechanisms of Tumorgenesis and Metastasis of Long Non-coding RNA (lncRNA) NEAT1 in Human Solid Tumors; An Update

An overview of lncRNA NEAT1 contribution in the pathogenesis of female cancers; from diagnosis to therapy resistance

NEAT1 As a Competing Endogenous RNA in Tumorigenesis of Various Cancers: Role, Mechanism and Therapeutic Potential

Molecular Interactions of the Long Noncoding RNA NEAT1 in Cancer

Long non-coding RNA NEAT1 confers oncogenic role in triple-negative breast cancer through modulating chemoresistance and cancer stemness

LncRNA NEAT1 in the pathogenesis of liver‐related diseases

Long Non-Coding RNA NEAT1 Promotes Non-Small Cell Lung Cancer Progression Through Regulation of Mir-377-3p-e2f3 Pathway.

Long Non-Coding RNA NEAT1 Overexpression is Associated with Poor Prognosis in Cancer Patients: a Systematic Review and Meta-Analysis

Pan-cancer analysis of long non-coding RNA NEAT1 in various cancers

LncRNA NEAT1 Promotes Deterioration of Hepatocellular Carcinoma Based on In Vitro Experiments, Data Mining, and RT-qPCR Analysis.

The Lncrna NEAT1 Inhibits Mirna-216B and Promotes Colorectal Cancer Progression by Indirectly Activating YY1

Neat Expression Is Associated With Tumor Recurrence And Unfavorable Prognosis In Colorectal Cancer

NEAT1 can be a diagnostic biomarker in the breast cancer and gastric cancer patients by targeting XIST, hsa-miR-612, and MTRNR2L8: integrated RNA targetome interaction and experimental expression analysis

LncRNA NEAT1 Interacted With DNMT1 to Regulate Malignant Phenotype of Cancer Cell and Cytotoxic T Cell Infiltration via Epigenetic Inhibition of p53, cGAS, and STING in Lung Cancer

585. Long Non-Coding RNA NEAT1 Functions As a Cerna to Regulate E2F3 Expression by Sponging Mir-377-3p in Non-Small Cell Lung Cancer

Long Noncoding Rna Neat1 Promotes The Growth Of Human Retinoblastoma Cells Via Regulation Of Mir-204/Cxcr4 Axis

Long Noncoding RNA Nuclear Paraspeckle Assembly Transcript 1 Promotes Progression and Angiogenesis of Esophageal Squamous Cell Carcinoma Through miR-590-3p/MDM2 Axis

Long non-coding RNA NEAT1 promotes aerobic glycolysis and progression of cervical cancer through WNT/β-catenin/PDK1 axis

Long noncoding RNA NEAT1 drives aggressive endometrial cancer progression via miR-361-regulated networks involving STAT3 and tumor microenvironment-related genes

Long Noncoding RNA NEAT1, Regulated by the EGFR Pathway, Contributes to Glioblastoma Progression Through the WNT/β-Catenin Pathway by Scaffolding EZH2.

Long non‐coding <scp>RNA NEAT1</scp> promotes aerobic glycolysis and progression of cervical cancer through <scp>WNT</scp>/β‐catenin/<scp>PDK1</scp> axis